GlassScriptPhysician profile
Isaac Ilaoa
NPI 1336415280
$2,060.97
in general payments reported to CMS, 2019-2025
18 companies · $419 in 2025
The $419 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.05 · 2021: $14.34 · 2022: $202 · 2023: $731 · 2024: $682 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,831.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $731.74 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $400.11 | 2021-2025 | Rexulti, Abilify Maintena |
| Supernus Pharmaceuticals, INC. | $380.76 | 2023-2024 | Qelbree, Qelbree |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $160.49 | 2025 | Caplyta |
| Pfizer INC. | $59.06 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.44 | 2024-2025 | |
| Novo Nordisk INC | $50.94 | 2024-2025 | Wegovy |
| Axsome Therapeutics, INC. | $44.73 | 2025 | Auvelity |
| Boston Scientific Corporation | $29.31 | 2022 | |
| Corium, LLC | $20.44 | 2022 | |
| Sanofi Pasteur INC. | $19.28 | 2023 | |
| Hologic Sales and Service, LLC | $19.03 | 2023 | Thinprep 2000 Processor |
| Sobi, INC | $17.62 | 2023 | |
| Merck Sharp & Dohme LLC | $17.20 | 2024 | Gardasil, Gardasil 9, M-M-R II |
| Mylan Specialty L.P. | $15.75 | 2023 | Yupelri |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $15.74 | 2024 | Airsupra |
| Kowa Pharmaceuticals America, INC. | $14.28 | 2023 | Livalo |
| Glaxosmithkline, LLC. | $13.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Ilaoa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.